New study tests immune combo before brain surgery in melanoma patients
NCT ID NCT05704933
First seen Nov 01, 2025 · Last updated May 01, 2026 · Updated 20 times
Summary
This early-phase study tested whether giving a single dose of nivolumab with either ipilimumab or relatlimab before brain surgery is safe and feasible in adults with melanoma that has spread to the brain. Only one person enrolled, so the main goal was to see if recruitment was possible. Researchers also looked at immune cell changes in the tumor and blood samples.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC MELANOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
M.D. Anderson Cancer Center
Houston, Texas, 77030, United States
-
Moffitt Cancer Center
Tampa, Florida, 33612, United States
Conditions
Explore the condition pages connected to this study.